image
Basic Materials - Chemicals - Specialty - NYSE - US
$ 39.23
10.4 %
$ 1.43 B
Market Cap
-3.31
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on May, 8, 2025.

The intrinsic value of one NGVT stock under the worst case scenario is HIDDEN Compared to the current market price of 39.2 USD, Ingevity Corporation is HIDDEN

This DCF valuation model was last updated on May, 8, 2025.

The intrinsic value of one NGVT stock under the base case scenario is HIDDEN Compared to the current market price of 39.2 USD, Ingevity Corporation is HIDDEN

This DCF valuation model was last updated on May, 8, 2025.

The intrinsic value of one NGVT stock under the best case scenario is HIDDEN Compared to the current market price of 39.2 USD, Ingevity Corporation is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart NGVT

image
$55.0$55.0$50.0$50.0$45.0$45.0$40.0$40.0$35.0$35.0$30.0$30.0$25.0$25.015 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '25
FINANCIALS
1.41 B REVENUE
-16.88%
260 M OPERATING INCOME
-9.82%
-430 M NET INCOME
-7868.52%
129 M OPERATING CASH FLOW
-37.30%
-79.5 M INVESTING CASH FLOW
-2.85%
-70.2 M FINANCING CASH FLOW
29.73%
284 M REVENUE
-4.95%
70.3 M OPERATING INCOME
27.36%
20.5 M NET INCOME
23.49%
25.4 M OPERATING CASH FLOW
-60.62%
-11.5 M INVESTING CASH FLOW
58.93%
-11 M FINANCING CASH FLOW
88.73%
Balance Sheet Ingevity Corporation
image
Current Assets 493 M
Cash & Short-Term Investments 68 M
Receivables 172 M
Other Current Assets 253 M
Non-Current Assets 1.53 B
Long-Term Investments 87.3 M
PP&E 709 M
Other Non-Current Assets 733 M
3.36 %8.50 %12.52 %4.32 %35.07 %36.23 %Total Assets$2.0b
Current Liabilities 264 M
Accounts Payable 94.5 M
Short-Term Debt 78.2 M
Other Current Liabilities 91.4 M
Non-Current Liabilities 1.56 B
Long-Term Debt 1.38 B
Other Non-Current Liabilities 187 M
5.17 %4.28 %5.00 %75.33 %10.22 %Total Liabilities$1.8b
EFFICIENCY
Earnings Waterfall Ingevity Corporation
image
Revenue 1.41 B
Cost Of Revenue 952 M
Gross Profit 455 M
Operating Expenses 195 M
Operating Income 260 M
Other Expenses 690 M
Net Income -430 M
2b2b1b1b1b1b1b1b800m800m600m600m400m400m200m200m00(200m)(200m)(400m)(400m)(600m)(600m)1b(952m)455m(195m)260m(690m)(430m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
32.33% GROSS MARGIN
32.33%
18.48% OPERATING MARGIN
18.48%
-30.60% NET MARGIN
-30.60%
-220.44% ROE
-220.44%
-21.27% ROA
-21.27%
11.37% ROIC
11.37%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Ingevity Corporation
image
250m250m200m200m150m150m100m100m50m50m00(50m)(50m)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -430 M
Depreciation & Amortization 108 M
Capital Expenditures -77.6 M
Stock-Based Compensation 11.9 M
Change in Working Capital -200 K
Others 499 M
Free Cash Flow 51 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Ingevity Corporation
image
Wall Street analysts predict an average 1-year price target for NGVT of $44.7 , with forecasts ranging from a low of $42 to a high of $47 .
NGVT Lowest Price Target Wall Street Target
42 USD 7.06%
NGVT Average Price Target Wall Street Target
44.7 USD 13.86%
NGVT Highest Price Target Wall Street Target
47 USD 19.81%
Price
Max Price Target
Min Price Target
Average Price Target
5555505045454040353530302525Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 10
6. Ownership
Insider Ownership Ingevity Corporation
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Ingevity Corporation (NGVT) Q1 2025 Earnings Call Transcript Ingevity Corporation (NYSE:NGVT ) Q1 2025 Results Conference Call May 6, 2025 9:00 AM ET Company Participants John Nypaver - Vice President, Treasurer & Investor Relations David Li - President & Chief Executive Officer Mary Dean Hall - Executive Vice President & Chief Financial Officer Conference Call Participants John McNulty - BMO Capital Markets Jon Tanwanteng - CJS Securities Daniel Rizzo - Jefferies Abigail Eberts - Wells Fargo Securities Operator Good morning or good afternoon. I welcome to the Ingevity First Quarter 2025 Earnings Call and Webcast. seekingalpha.com - 1 week ago
Ingevity reports first quarter 2025 financial results NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity Corporation (NYSE: NGVT) today reported its financial results for the first quarter of 2025. businesswire.com - 2 weeks ago
Ingevity announces dates for first-quarter 2025 earnings release and webcast NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity announces dates for first-quarter 2025 earnings release and webcast. businesswire.com - 3 weeks ago
Here's Why You Should Add Ingevity Stock to Your Portfolio NGVT benefits from the repositioning of its Performance Chemicals segment, strategic acquisitions and actions to drive growth. zacks.com - 1 month ago
Ingevity's Shares Up 10% in 6 Months: What's Driving the Stock? NGVT gains on the repositioning of its Performance Chemicals segment, strategic acquisitions and actions to drive growth. zacks.com - 1 month ago
Ingevity Files Definitive Proxy Statement and Issues Letter to Stockholders NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity today announced that it has filed its definitive proxy statement with the U.S. SEC in connection with its 2025 Annual Meeting. businesswire.com - 1 month ago
Why Is Ingevity (NGVT) Down 8.3% Since Last Earnings Report? Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock? zacks.com - 1 month ago
Why Ingevity (NGVT) is a Top Momentum Stock for the Long-Term Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. zacks.com - 2 months ago
Ingevity announces appointment of David H. Li as president and CEO NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity announced that its board of directors has appointed David H. Li as the company's president and CEO, effective as of April 7, 2025. businesswire.com - 2 months ago
Here's What Makes Ingevity Stock a Solid Choice Right Now NGVT benefits from the repositioning of its Performance Chemicals segment to rationalize its manufacturing footprint and strategic acquisitions. zacks.com - 2 months ago
Zacks Industry Outlook Axalta Coating, Ingevity and Flexible Solutions International Axalta Coating, Ingevity and Flexible Solutions International have been highlighted in this Industry Outlook article. zacks.com - 2 months ago
5 Stocks With Upgraded Broker Ratings Worth Betting on Now Brokers have more insights into stocks and the macroeconomic backdrop. One must follow broker rating upgrades to pick stocks like NGVT, STRL, NVDA, PYPL & AAL. zacks.com - 2 months ago
8. Profile Summary

Ingevity Corporation NGVT

image
COUNTRY US
INDUSTRY Chemicals - Specialty
MARKET CAP $ 1.43 B
Dividend Yield 0.00%
Description Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, motorcycles, trucks, and boats. This segment also produces other activated carbon products for use in various applications, including food, water, beverage, and chemical purification. The Performance Chemicals segment comprises of pavement technologies, industrial specialties, and engineered polymers. It manufactures products derived from crude tall oil and lignin extracted from the kraft pulping process, as well as caprolactone monomers and derivatives derived from cyclohexanone and hydrogen peroxide. This segment's products are used in various applications comprising warm mix paving, pavement preservation, pavement reconstruction and recycling, oil well service additives, oil production, and downstream applications; and adhesives, agrochemical dispersants, lubricants, printing inks, industrial intermediates and oilfield, coatings, resins, elastomers, bioplastics, and medical devices. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.
Contact 4920 O'Hear Avenue, North Charleston, SC, 29405 https://www.ingevity.com
IPO Date May 3, 2016
Employees 1600
Officers Mr. Richard A. White Jr. Senior Vice President & President of Performance Chemicals Mr. Michael N. Shukov Senior Vice President & President of Advanced Polymer Technologies Mr. David H. Li President, Chief Executive Officer & Director Caroline Monahan Director of Communications Ms. Mary Dean Hall Executive Vice President & Chief Financial Officer Mr. Stuart Edward Woodcock Jr. Executive Vice President & President of Performance Materials John E. Nypaver Jr. Vice President of Investor Relations & Treasurer Mr. Terrance M. Dyer Senior Vice President & Chief Human Resources Officer Mr. Ryan C. Fisher Senior Vice President, General Counsel & Secretary Mr. Phillip John Platt Senior Vice President of Finance & Chief Accounting Officer